CEO Pablo Legorreta emphasized a strong start to 2025, highlighting 12% growth in Royalty Receipts and a 17% increase in Portfolio Receipts, driven by the company's diversified portfolio and milestone ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with a current share capital of DKK 60,642,144. The company ...

So far in his second term, President Donald Trump has been trying to coerce international corporations to bolster their spending in the United States, including through his controversial tariffs. But ...

Royalty Pharma's stock has underperformed recently, down 7% year to date while the S&P500 has climbed 13%. In the company's latest Q2'24 results, Royalty Pharma reported a 12% increase in portfolio ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The agreement makes the ...